98%
921
2 minutes
20
The purpose of this study was to investigate the safety and efficacy of Rest-ZZZ, a natural sleep supplement, in healthy adults without a diagnosed sleep disorder. This randomized, double-blind, placebo-controlled, cross-over study consisted of three 7-day supplementation periods with either Rest-ZZZ, Diphenhydramine (DPH), or Placebo, with a 7-day washout. Twenty-seven participants were randomized to one of three intervention sequences and the Healthy People Sleep Quality Index (HPSQI), Quality of Life (QoL), and Profile of Mood States (POMS) questionnaires were assessed at the beginning and end of each supplementation period. Rest-ZZZ and Placebo showed improvements in sleep-related QoL ( ≤ 0.044) and total mood disturbance (TMD) ( = ≤ 0.028). Fatigue-Inertia was reduced by all study products ( ≤ 0.031). DPH did not result in any significant improvements on sleep quality parameters. A subgroup analysis of participants ≤ 45 years found enhanced efficacy of Rest-ZZZ and improvement in sleep-related QoL vs. Placebo ( = 0.007), as well as improvements in sleep duration ( = 0.007), sleep debt ( = 0.011), and sleep-related QoL ( = 0.033). DPH supplementation resulted in significant improvement in only sleep debt ( = 0.038). Rest-ZZZ had a safe hematology and chemistry profile. Rest-ZZZ resulted in restful sleep that generated corresponding improvements in sleep-related QoL and overall mood. Rest-ZZZ is an efficacious sleep supplement with a favorable safety profile, particularly in those aged 25-45 years.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10900002 | PMC |
http://dx.doi.org/10.1007/s41105-022-00416-2 | DOI Listing |
Front Neurol
July 2025
Department of Neurology, All India Institute of Medical Sciences, New Delhi, India.
Background: Post-stroke sleep disorders (PSSD) are under-reported and under-treated, despite their impact on recovery, quality of life, and post-stroke depression. Although polysomnography (PSG) is the gold standard for diagnosis, its limited availability leads to underdiagnosis.
Aims: To assess the prevalence of PSSD based on patient- and caregiver-reported data, and to evaluate their concordance with findings from overnight PSG in post-stroke patients.
Respir Med
October 2025
Gazi University, Faculty of Health Sciences, Department of Physical Therapy and Rehabilitation, Ankara, Turkey. Electronic address:
Background: Growing evidence indicates that Sleep bruxism (SB) is recognized as a multifaceted condition that potentially has systemic implications, including effects on respiratory functions, exercise capacity, and possibly other body systems, which may reduce overall quality of life (QOL). This study aimed to investigate respiratory functions, respiratory muscle performance, functional capacity, and QOL in individuals with SB compared to healthy controls.
Materials And Methods: This study included 47 individuals with probable SB and 21 healthy controls.
J Med Internet Res
June 2025
College of Nursing, Research Institute of AI and Nursing Science, Gachon University, Incheon, Republic of Korea.
Background: Insomnia is a common sleep disorder, especially among older adults, with a significant impact on the quality of life (QoL) and is associated with various comorbidities. Traditional pharmacotherapy for insomnia is often unsuitable for older adults because of potential drug interactions and side effects, making nonpharmacological interventions such as cognitive behavioral therapy for insomnia (CBT-I) more appropriate. However, delivering CBT-I in a traditional face-to-face setting poses challenges including accessibility and adherence, particularly for older adults.
View Article and Find Full Text PDFFront Psychiatry
May 2025
Department of Sleep-Wake Disorders, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan.
Background: Insomnia is a quality of life (QOL) disorder complicated by various mental or physical daytime dysfunctions in addition to nocturnal insomnia symptoms. This study aimed to develop and examine the reliability and validity of a self-administered scale that can sensitively and easily assess QOL disturbances in patients with insomnia.
Methods: From 122 patients with primary insomnia (mean age 53.
Eur J Nutr
March 2025
Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.
Background: To strengthen the scientific evidence linking dietary sugar consumption with health outcomes, it's essential to look beyond the usual focus on non-communicable diseases (NCDs) and tooth decay. We thus hypothesize that considering other dimensions of health beyond physical health will meaningfully complement the evidence and expand our understanding of the relationship between nutrition and health.
Purpose: The aim of this scoping review was to explore the scientific evidence of an association between dietary sugar intake and quality of life (QoL) among healthy children and adolescents.